Disclaim

Enter the country in which you reside:

I am currently present in:

 

 

IMPORTANT INFORMATION

Due to legal restrictions, the information on this part of Sedana Medical’s website is not accessible to certain persons. We kindly ask you to review the following information and provide the following confirmation each time you wish to access these websites. Please note that the terms set out below may be altered or updated and therefore it is important that you review them each time you visit this page.

The information contained in this section of Sedana Medical’s website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law, and do not constitute any offer regarding shares or other securities in Sedana Medical (“Securities”) to any person in said jurisdictions. Nor may the information on the websites be forwarded or reproduced in such a manner that contravenes such restrictions or gives cause to such requirements.

No action has been taken by the Company that would permit an offer of Securities or the possession or distribution of any materials found in this section of Sedana Medical’s website or any other offering or publicity material relating to such Securities in any jurisdiction where action for that purpose is required. The release, publication or distribution of such materials in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions.

No Securities have been, and will not be, registered under the United States Securities Act of 1933, as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States and may not be offered, subscribed for, used, pledged, sold, resold, delivered or otherwise transferred, directly or indirectly, in or into the United States except under an available exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States.

No public offering of Securities is made to any countries within the European Economic Area (“EEA”) and the information contained in this section of Sedana Medical’s website is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”).

In the United Kingdom, the information contained in this section of Sedana Medical’s website and any other materials in relation to the securities described herein are only being distributed to, and are only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” (within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of UK law by virtue of the EU (Withdrawal) Act 2018) who (i) have professional experience in matters relating to investments which fall within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) are persons falling within Article 49(2)(a) to (d) of the Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This press release is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this press release relates is available only to relevant persons and will be engaged in only with relevant persons.

To access the information contained in this section of Sedana Medical’s website, all persons must first ensure that they are not subject to legal restrictions that limit their right to access the information on this part of Sedana Medical’s website.

We therefore ask you to confirm that you are resident or physically present outside the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, and South Africa and that you are entitled to access the information in this section of Sedana Medical’s website without being subject to restrictions under any laws or other regulations and without any further action being required by Sedana Medical. We also ask you to confirm that you have read the information, conditions and restrictions above, and confirm that you agree to comply with these.


Yes, I confirm No, I do not confirm

 

 

The information contained in this section of the website is restricted and is not for release, publication, or distribution, directly or indirectly, in whole or in part, into or from United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

We apologise for any inconvenience this may cause.


Homepage

 

The information contained in this section of the website is restricted and is not for release, publication, or distribution, directly or indirectly, in whole or in part, into or from United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

We apologise for any inconvenience this may cause.


Homepage

 

The information contained in this section of the website is restricted and is not for release, publication, or distribution, directly or indirectly, in whole or in part, into or from United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

We apologise for any inconvenience this may cause.


Homepage

 

The information contained in this section of the website is restricted and is not for release, publication, or distribution, directly or indirectly, in whole or in part, into or from United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

We apologise for any inconvenience this may cause.


Homepage

 

The information contained in this section of the website is restricted and is not for release, publication, or distribution, directly or indirectly, in whole or in part, into or from United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any jurisdiction where to do so might constitute a violation of the local securities laws or regulations of such jurisdiction.

We apologise for any inconvenience this may cause.


Homepage

 

IMPORTANT INFORMATION

Due to legal restrictions, the information on this part of Sedana Medical’s website is not accessible to certain persons. We kindly ask you to review the following information and provide the following confirmation each time you wish to access these websites. Please note that the terms set out below may be altered or updated and therefore it is important that you review them each time you visit this page.

The information contained in this section of Sedana Medical’s website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law, and do not constitute any offer regarding shares or other securities in Sedana Medical (“Securities”) to any person in said jurisdictions. Nor may the information on the websites be forwarded or reproduced in such a manner that contravenes such restrictions or gives cause to such requirements.

No action has been taken by the Company that would permit an offer of Securities or the possession or distribution of any materials found in this section of Sedana Medical’s website or any other offering or publicity material relating to such Securities in any jurisdiction where action for that purpose is required. The release, publication or distribution of such materials in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions.

No Securities have been, and will not be, registered under the United States Securities Act of 1933, as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States and may not be offered, subscribed for, used, pledged, sold, resold, delivered or otherwise transferred, directly or indirectly, in or into the United States except under an available exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States.

No public offering of Securities is made to any countries within the European Economic Area (“EEA”) and the information contained in this section of Sedana Medical’s website is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”).

In the United Kingdom, the information contained in this section of Sedana Medical’s website and any other materials in relation to the securities described herein are only being distributed to, and are only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” (within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of UK law by virtue of the EU (Withdrawal) Act 2018) who (i) have professional experience in matters relating to investments which fall within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) are persons falling within Article 49(2)(a) to (d) of the Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This press release is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this press release relates is available only to relevant persons and will be engaged in only with relevant persons.

To access the information contained in this section of Sedana Medical’s website, all persons must first ensure that they are not subject to legal restrictions that limit their right to access the information on this part of Sedana Medical’s website.

We therefore ask you to confirm that you are resident or physically present outside the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, and South Africa and that you are entitled to access the information in this section of Sedana Medical’s website without being subject to restrictions under any laws or other regulations and without any further action being required by Sedana Medical. We also ask you to confirm that you have read the information, conditions and restrictions above, and confirm that you agree to comply with these.


Yes, I confirm No, I do not confirm

 

 

IMPORTANT INFORMATION

Due to legal restrictions, the information on this part of Sedana Medical’s website is not accessible to certain persons. We kindly ask you to review the following information and provide the following confirmation each time you wish to access these websites. Please note that the terms set out below may be altered or updated and therefore it is important that you review them each time you visit this page.

The information contained in this section of Sedana Medical’s website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law, and do not constitute any offer regarding shares or other securities in Sedana Medical (“Securities”) to any person in said jurisdictions. Nor may the information on the websites be forwarded or reproduced in such a manner that contravenes such restrictions or gives cause to such requirements.

No action has been taken by the Company that would permit an offer of Securities or the possession or distribution of any materials found in this section of Sedana Medical’s website or any other offering or publicity material relating to such Securities in any jurisdiction where action for that purpose is required. The release, publication or distribution of such materials in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions.

No Securities have been, and will not be, registered under the United States Securities Act of 1933, as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States and may not be offered, subscribed for, used, pledged, sold, resold, delivered or otherwise transferred, directly or indirectly, in or into the United States except under an available exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States.

No public offering of Securities is made to any countries within the European Economic Area (“EEA”) and the information contained in this section of Sedana Medical’s website is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”).

In the United Kingdom, the information contained in this section of Sedana Medical’s website and any other materials in relation to the securities described herein are only being distributed to, and are only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” (within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of UK law by virtue of the EU (Withdrawal) Act 2018) who (i) have professional experience in matters relating to investments which fall within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) are persons falling within Article 49(2)(a) to (d) of the Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This press release is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this press release relates is available only to relevant persons and will be engaged in only with relevant persons.

To access the information contained in this section of Sedana Medical’s website, all persons must first ensure that they are not subject to legal restrictions that limit their right to access the information on this part of Sedana Medical’s website.

We therefore ask you to confirm that you are resident or physically present outside the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, and South Africa and that you are entitled to access the information in this section of Sedana Medical’s website without being subject to restrictions under any laws or other regulations and without any further action being required by Sedana Medical. We also ask you to confirm that you have read the information, conditions and restrictions above, and confirm that you agree to comply with these.


Yes, I confirm No, I do not confirm

 

 

IMPORTANT INFORMATION

Due to legal restrictions, the information on this part of Sedana Medical’s website is not accessible to certain persons. We kindly ask you to review the following information and provide the following confirmation each time you wish to access these websites. Please note that the terms set out below may be altered or updated and therefore it is important that you review them each time you visit this page.

The information contained in this section of Sedana Medical’s website is not intended for, and must not be accessed by, or distributed or disseminated, directly or indirectly, in whole or in part, to persons resident or physically present in the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, South Africa or any other jurisdiction where such action is wholly or partially subject to legal restrictions, or would require additional prospectuses, registration or other measures than those required by Swedish law, and do not constitute any offer regarding shares or other securities in Sedana Medical (“Securities”) to any person in said jurisdictions. Nor may the information on the websites be forwarded or reproduced in such a manner that contravenes such restrictions or gives cause to such requirements.

No action has been taken by the Company that would permit an offer of Securities or the possession or distribution of any materials found in this section of Sedana Medical’s website or any other offering or publicity material relating to such Securities in any jurisdiction where action for that purpose is required. The release, publication or distribution of such materials in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which they are released, published or distributed, should inform themselves about, and observe, such restrictions.

No Securities have been, and will not be, registered under the United States Securities Act of 1933, as amended (the “Securities Act”) or the securities legislation of any state or other jurisdiction in the United States and may not be offered, subscribed for, used, pledged, sold, resold, delivered or otherwise transferred, directly or indirectly, in or into the United States except under an available exemption from, or in a transaction not subject to, the registration requirements under the Securities Act and in compliance with the securities legislation in the relevant state or any other jurisdiction of the United States.

No public offering of Securities is made to any countries within the European Economic Area (“EEA”) and the information contained in this section of Sedana Medical’s website is not a prospectus for the purposes of Regulation (EU) 2017/1129 of the European Parliament and of the Council of 14 June 2017 on the prospectus to be published when securities are offered to the public or admitted to trading on a regulated market, and repealing Directive 2003/71/EC (together with any related implementing and delegated regulations, the “Prospectus Regulation”).

In the United Kingdom, the information contained in this section of Sedana Medical’s website and any other materials in relation to the securities described herein are only being distributed to, and are only directed at, and any investment or investment activity to which this document relates is available only to, and will be engaged in only with, “qualified investors” (within the meaning of the Prospectus Regulation (Regulation (EU) 2017/1129) as it forms part of UK law by virtue of the EU (Withdrawal) Act 2018) who (i) have professional experience in matters relating to investments which fall within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) are persons falling within Article 49(2)(a) to (d) of the Order, (iii) are outside the United Kingdom, or (iv) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as “relevant persons”). This press release is directed only at relevant persons and must not be acted on or relied on by persons who are not relevant persons. Any investment or investment activity to which this press release relates is available only to relevant persons and will be engaged in only with relevant persons.

To access the information contained in this section of Sedana Medical’s website, all persons must first ensure that they are not subject to legal restrictions that limit their right to access the information on this part of Sedana Medical’s website.

We therefore ask you to confirm that you are resident or physically present outside the United States, Australia, Canada, New Zealand, Hong Kong, Japan, Singapore, and South Africa and that you are entitled to access the information in this section of Sedana Medical’s website without being subject to restrictions under any laws or other regulations and without any further action being required by Sedana Medical. We also ask you to confirm that you have read the information, conditions and restrictions above, and confirm that you agree to comply with these.


Yes, I confirm No, I do not confirm